Synvida
Latest round
- Series A
Last raised
- Jan 2024
Total raised
- $28M
Investors
- 2
About Synvida
Based in Shanghai, China, and founded in 2021, Synvida is a biopharmaceutical company focusing on drug research and development in the fields of coagulation and fibrosis. The founder, Junling Liu is a vice chairman of the Society of Vascular Medicine - Chinese Association of Pathophysiology. In December 2023, the IPF treatment antibody clinical trial application was approved by CDE (Center for Drug Evaluation). The company is committed to establishing original targets and molecular pipelines in the field of coagulation such as pulmonary fibrosis, thrombocytopenia, hemophilia, and thrombotic diseases. It has developed the EMPRESS system for constructing fully synthetic bacteriophages and yeast libraries. The company will use the series A funds to promote the clinical and preclinical research of the company's pipelines.
Who invested in Synvida
2 investors across 1 round
See all investors in Synvida
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 10, 2024
Amount
$28M
Investors
Questions about Synvida
Who invested in Synvida?
Synvida has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synvida raised?
Synvida has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Synvida last raise money?
Synvida's most recent round on record is a Series A, in Jan 2024.
What does Synvida do?
Based in Shanghai, China, and founded in 2021, Synvida is a biopharmaceutical company focusing on drug research and development in the fields of coagulation and fibrosis.
Where is Synvida headquartered?
Synvida is headquartered in Shanghai, China.
Which VCs invest in companies like Synvida?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Synvida's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Synvida? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.